31 May 2025 in Journal of Investigative Medicine High Impact Case Reports
Immunotherapy has become the standard of care for advanced and resectable lung cancer, and specific mutations may predict immunotherapy response. For example, STK11 mutations, which are more common in African American patients, are associated with immunotherapy resistance. A 68-year-old African American man with stage IIIB lung adenocarcinoma with mediastinal lymph node involvement progressed on first-line concurrent carboplatin-based chemoradiotherapy. Molecular testing of the patient’s subcarinal lymph node tissue revealed STK11 S216F, TP53 R273L, and RB1 splice site mutations; high tumor mutation burden (19.0 mutations/Mb); and high PD-L1 22c3 expression (TPS 70%, 2+ intensity). Treatment with carboplatin-based chemotherapy with radiation therapy failed to control the disease, but the patient has tolerated and responded well to intravenous pembrolizumab. Although STK11 mutations are associated with immunotherapy resistance, our patient demonstrated an exceptional and sustained response to immunotherapy for over two years. The patient’s STK11/TP53 co-mutation, along with high TMB and PD-L1 22c3 TPS scores, may help explain his continued responsiveness to immunotherapy and longer survival. Importantly, incorporating genetic ancestry differences in mutation prevalence and the impact of specific mutations and co-mutations, may help ensure the equitable and optimal treatment of all patients with lung cancers.
1 May 2025 in Journal of Investigative Medicine High Impact Case Reports
Tracheobronchopathia osteochondroplastica (TPO) is a rare, benign condition characterized by the presence of submucosal cartilaginous and osseous nodules protruding into the anterior and lateral walls of the tracheobronchial lumen, sparing the posterior membranous wall. These nodules are incidentally discovered on imaging and bronchoscopy performed for unrelated respiratory symptoms. The exact etiopathogenesis is unclear, with various hypotheses proposed. The most widely accepted one is that chronic inflammation leads to cartilaginous and osseous metaplasia of the tracheobronchial submucosa. TPO is rare, with the prevalence further underestimated due to the incidental nature of the diagnosis. Clinically, patients may be asymptomatic or can have nonspecific symptoms such as chronic cough, dyspnea, and recurrent respiratory infections. Suspicion of the diagnosis arises upon incidental identification of nodules in the tracheobronchial lumen. Diagnosis is established through bronchoscopic visualization of characteristic nodular lesions sparing the posterior wall and can be confirmed by histopathologic examination showing submucosal cartilage formation and ossification. Management is generally conservative, focusing on symptomatic relief and treatment of infections. Severe cases with significant airway obstruction may warrant advanced bronchoscopic procedures or surgical interventions. Despite its benign nature, TPO can mimic other serious tracheal diseases. Awareness of this condition is essential for accurate diagnosis and appropriate management. We present a case of a 65-year-old asymptomatic chronic smoker who was found to have tracheal nodules on thoracic imaging. Bronchoscopic evaluation was consistent with TPO, with histopathology reaffirming the diagnosis.
23 October 2020 in Medicine
Lung cancer is 1 of the leading causes of cancer-related deaths and bronchoscopy is an essential tool for the diagnosis. The diagnostic yield varies based on the characteristics of the lesion and bronchoscopic techniques employed. There is limited data regarding outcomes of patients suspected of thoracic malignancies with a non-diagnostic initial bronchoscopy. The goal of the study was to evaluate the outcomes of patients with a non-diagnostic bronchoscopy for suspected thoracic malignancies and to evaluate variables predictive of a diagnostic bronchoscopy. Retrospective analysis of adult patients at BronxCare Hospital Center who underwent bronchoscopy for suspected thoracic malignancy. The study period was January 2012 to February 2019. Exclusion criteria included patients who underwent only inspection bronchoscopy or bronchoalveolar lavage as the diagnostic yield for malignancy with these techniques is low. All other bronchoscopic procedures were included that is, endobronchial biopsies, transbronchial biopsies, and endobronchial ultrasound guided-transbronchial needle aspiration. Bronchoscopy was considered diagnostic when a specific histopathological diagnosis was established. 311 patients underwent bronchoscopy to rule out malignancy. A diagnosis was obtained in 153 (49.2%) patients, 81 (52.9%) had primary lung cancer and 14 (9.15%) other malignancies. 158 (50.8%) patients had initial non-diagnostic bronchoscopy; 86 (54.43%) were lost to follow up. Of the remaining 72 (45.57%) patients, radiological resolution or stability was observed in 51 (70.8%) patients. Primary lung cancer was found in 13 (18.05%) patients and other malignancies in 5 (6.94%). Predictive of a diagnostic bronchoscopy was the performance of endobronchial biopsies and endobronchial ultrasound guided-transbronchial needle aspiration. This study highlights some of the barriers to the timely diagnosis of thoracic malignancies. Following patients with a non-diagnostic procedure as well as all those patients with diagnosed malignancies it of the utmost importance. In patients available for follow up, close to 25% of additional cases with treatable malignancy could be identified and patients diagnosed with cancer could receive timely treatment.
5 January 2026 in Respirology Case Reports
NMNaga Vamsi Krishna Machineni
Naga Vamsi Krishna Machineni
Endometrial carcinoma is the most common gynecologic malignancy in developed countries and is typically diagnosed at an early stage, with distant metastases uncommon at presentation. Pulmonary involvement occurs in less than 5% of cases and usually manifests as small nodules or interstitial disease; the appearance of multiple, large, round ‘cannonball’ metastases is exceptionally rare. We report the case of a 60‐year‐old woman who presented with cough and dyspnea. Imaging revealed numerous bilateral pulmonary ‘cannonball’ nodules, mediastinal lymphadenopathy, hepatic lesions, and an enlarged uterus. Endometrial biopsy confirmed endometrioid adenocarcinoma, staged as FIGO IV‐B. The patient underwent chemotherapy with carboplatin and paclitaxel, resulting in significant regression of pulmonary and hepatic metastases and symptomatic improvement, followed by maintenance therapy with anastrozole that achieved stable disease on surveillance. This case highlights the importance of recognising cannonball pulmonary metastases as a potential, albeit rare, initial presentation of endometrial carcinoma, thereby guiding timely diagnosis and treatment.
20 August 2025 in Journal of Investigative Medicine High Impact Case Reports
Bronchus-associated lymphoid tissue (BALT) lymphoma is a rare subtype of extra-nodal marginal zone B-cell lymphomas, accounting for less than 5% of cases. It is typically indolent and often discovered incidentally through imaging studies performed for unrelated reasons. We present the case of a 72-year-old male with a known history of thoracic aortic dilatation, who was found to have a spiculated right upper lobe (RUL) pulmonary nodule on surveillance imaging. He remained asymptomatic, with no constitutional or respiratory symptoms. Positron emission tomography imaging demonstrated mildly increased uptake (standardized uptake value 2.4) of the RUL nodule, and no mediastinal or hilar lymphadenopathy. Bronchoscopic biopsy with histopathology and immunohistochemistry revealed a low-grade B-cell non-Hodgkin’s lymphoma, with CD20 and BCL2 positivity. Flow cytometry confirmed monoclonal B-cell proliferation, and fluorescence in situ hybridization analysis identified the BIRC3-MALT1 translocation, consistent with BALT lymphoma. The patient was staged as IE, and a decision was made for conservative management with active surveillance, given the localized and asymptomatic nature of his disease. While treatment options may include surgery, radiotherapy, immunotherapy, or chemotherapy, there is no consensus on the optimal approach due to the rarity and heterogeneous presentation of this lymphoma. In many early-stage cases without symptoms, a “watch and wait” strategy is reasonable. This case underscores the importance of including BALT lymphoma in the differential diagnosis of incidental pulmonary nodules and highlights the need for greater awareness and research to establish standardized treatment protocols, with each case adding valuable insight to guide future management strategies.
5 March 2026 in Clinical Case Reports
Patients with Poland syndrome, especially those with left‐sided defects accompanied by dextrocardia, may be predisposed to significant respiratory and cardiac complications. This case underscores the importance of early recognition, thorough cardiopulmonary assessment, and proactive planning for airway management and ventilatory support to optimize outcomes during acute illness.